Novavax says COVID vaccines will be much like annual flu shots

Executive vice president wishes for a 'clear path' into China as demand wanes

20230112 Novavax interview

Novavax's COVID-19 vaccine shots, which can be stored in a regular refrigerator, had a 90% efficacy in their clinical trial. (Nikkei montage/Novavax/Reuters)

AKITO TANAKA, Nikkei Asia chief business news correspondent

SINGAPORE -- Future sales of COVID-19 vaccines will take place in "an annual vaccination market, a lot like influenza," according to Novavax's executive vice president.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.